These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10379189)

  • 21. Treatment of orthostatic hypotension with octreotide.
    Hoeldtke RD; Israel BC
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1051-9. PubMed ID: 2723026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effects of octreotide, cabergoline and a combination of both drugs on GH secretion in acromegalic patients.
    Minniti G; Jaffrain-Rea ML; Baldelli R; Ferretti E; Caracciolo B; Bultrini A; Gulino A; Tamburrano G
    Clin Ter; 1997 Dec; 148(12):601-7. PubMed ID: 9528195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of somatostatin analog in the treatment of hypotension during bowel surgery.
    Comunale ME; Neilly SA
    J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):606-8. PubMed ID: 1421073
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of propofol and isoflurane anaesthesia: the need for ephedrine and glycopyrrolate.
    Jensen AG; Granfeldt H; Kalman SH; Nyström PO; Eintrei C
    Eur J Anaesthesiol; 1995 May; 12(3):291-9. PubMed ID: 7641720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of carcinoid syndrome with a somatostatin analogue].
    Döbrönte Z; Stöckert A; Végh G; Varga L
    Orv Hetil; 1992 Mar; 133(12):731-4. PubMed ID: 1372969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A paraneoplastic syndrome associated with glomus tumors of the skull base? Early observations.
    Jackson CG; Gulya AJ; Knox GW; Glasscock ME; Pensak ML; Poe DS; Johnson GD
    Otolaryngol Head Neck Surg; 1989 Jun; 100(6):583-7. PubMed ID: 2546116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significance of the dosage adjustment of octreotide in the treatment of acute pancreatitis of moderate severity.
    Nikou GC; Arnaoutis TP; Giamarellos-Bourboulis EJ; Samolada O; Vafiadis-Zouboulis I; Katsilambros N; Arvanitakis C
    Hepatogastroenterology; 2001; 48(42):1754-7. PubMed ID: 11813617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of administering a minimal dose of octreotide long-term prior to surgery for insulinoma: report of a case.
    Tanaka Y; Funahashi H; Imai T; Naruse T; Suzumura K; Oda Y
    Surg Today; 2000; 30(6):541-3. PubMed ID: 10883468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Octreotide-induced bradycardia and heart block during surgical resection of a carcinoid tumor.
    Dilger JA; Rho EH; Que FG; Sprung J
    Anesth Analg; 2004 Feb; 98(2):318-320. PubMed ID: 14742361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for octreotide subcutaneously in the treatment of acromegaly.
    Liuzzi A; Oppizzi G
    J Endocrinol; 1997 Oct; 155 Suppl 1():S61-5. PubMed ID: 9389999
    [No Abstract]   [Full Text] [Related]  

  • 31. [Management of intraoperative carcinoid crises].
    Dralle H
    Chirurg; 2016 Jul; 87(7):610. PubMed ID: 27251478
    [No Abstract]   [Full Text] [Related]  

  • 32. A prospective multicenter octreotide dose response study in the treatment of acromegaly.
    Ezzat S; Redelmeier DA; Gnehm M; Harris AG
    J Endocrinol Invest; 1995 May; 18(5):364-9. PubMed ID: 7594225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatotropinomas inadequately controlled with octreotide may over-respond to pasireotide: the importance of dose adjustment to achieve long-term biochemical control.
    Shimon I; Saeger W; Wildemberg LE; Gadelha MR
    Hormones (Athens); 2017 Jan; 16(1):84-91. PubMed ID: 28500831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical management of previously untreated glomus jugulare tumors.
    Green JD; Brackmann DE; Nguyen CD; Arriaga MA; Telischi FF; De la Cruz A
    Laryngoscope; 1994 Aug; 104(8 Pt 1):917-21. PubMed ID: 8052073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complex tumors of the glomus jugulare: criteria, treatment, and outcome.
    Al-Mefty O; Teixeira A
    J Neurosurg; 2002 Dec; 97(6):1356-66. PubMed ID: 12507134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
    Iglesias P; Díez JJ
    J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of nebulized salbutamol in patients with bronchospasm during anaesthesia: a clinical trial.
    Vichitvejpaisal P; Svastdi-Xuto O; Udompunturux S
    J Med Assoc Thai; 1991 Sep; 74(9):397-403. PubMed ID: 1791394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of octreotide treatment and transsphenoidal surgery on growth hormone-binding protein levels in patients with acromegaly.
    Hernandez I; Soderlund D; Espinosa-de-los-Monteros AL; Ochoa R; Zarate A; Mercado M
    J Neurosurg; 1999 Apr; 90(4):647-50. PubMed ID: 10193608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoid tumor and intravenous octreotide infusion during labor and delivery.
    Le BT; Bharadwaj S; Malinow AM
    Int J Obstet Anesth; 2009 Apr; 18(2):182-5. PubMed ID: 19200714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure.
    Vallurupalli S
    Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.